期刊论文详细信息
Virology Journal
The detectable anti-interferon-γ autoantibodies in COVID-19 patients may be associated with disease severity
Research
Chia-Hui Chou1  Tsai-Ling Liao2  Kai-Jieh Yeo3  Ching-Kun Chang3  Shih-Hsin Chang4  Joung-Liang Lan5  Po-Ku Chen6  Der-Yuan Chen7 
[1] College of Medicine, China Medical University, Taichung, Taiwan;Division of Infection, China Medical University Hospital, Taichung, Taiwan;Ph.D. Program in Translational Medicine and Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan;Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan;Rheumatology and Immunology Center, China Medical University Hospital, No. 2, Yude Road, 40447, Taichung, Taiwan;College of Medicine, China Medical University, Taichung, Taiwan;Rheumatology and Immunology Center, China Medical University Hospital, No. 2, Yude Road, 40447, Taichung, Taiwan;College of Medicine, China Medical University, Taichung, Taiwan;Ph.D. Program in Translational Medicine and Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan;Rheumatology and Immunology Center, China Medical University Hospital, No. 2, Yude Road, 40447, Taichung, Taiwan;College of Medicine, China Medical University, Taichung, Taiwan;Rheumatic Diseases Research Center, China Medical University Hospital, Taichung, Taiwan;Rheumatology and Immunology Center, China Medical University Hospital, No. 2, Yude Road, 40447, Taichung, Taiwan;College of Medicine, China Medical University, Taichung, Taiwan;Translational Medicine Laboratory, Rheumatology and Immunology Center, Taichung, Taiwan;Rheumatology and Immunology Center, China Medical University Hospital, No. 2, Yude Road, 40447, Taichung, Taiwan;College of Medicine, China Medical University, Taichung, Taiwan;Translational Medicine Laboratory, Rheumatology and Immunology Center, Taichung, Taiwan;Ph.D. Program in Translational Medicine and Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan;
关键词: SARS-CoV-2;    Anti-interferon-γ auto-Abs;    Titers;    Disease severity;    COVID-19;   
DOI  :  10.1186/s12985-023-01989-1
 received in 2022-11-10, accepted in 2023-02-08,  发布年份 2023
来源: Springer
PDF
【 摘 要 】

BackgroundNeutralizing anti-interferon (IFN)-γ autoantibodies are linked to adult-onset immunodeficiency and opportunistic infections.MethodsTo explore whether anti-IFN-γ autoantibodies are associated with disease severity of coronavirus disease 2019 (COVID-19), we examined the titers and functional neutralization of anti-IFN-γ autoantibodies in COVID-19 patients. In 127 COVID-19 patients and 22 healthy controls, serum titers of anti-IFN-γ autoantibodies were quantified using enzyme-linked immunosorbent assay, and the presence of autoantibodies was verified with immunoblotting assay. The neutralizing capacity against IFN-γ was evaluated with flow cytometry analysis and immunoblotting, and serum cytokines levels were determined using the MULTIPLEX platform.ResultsA higher proportion of severe/critical COVID-19 patients had positivity for anti-IFN-γ autoantibodies (18.0%) compared with non-severe patients (3.4%, p < 0.01) or healthy control (HC) (0.0%, p < 0.05). Severe/critical COVID-19 patients also had higher median titers of anti-IFN-γ autoantibodies (5.01) compared with non-severe patients (1.33) or HC (0.44). The immunoblotting assay could verify the detectable anti-IFN-γ autoantibodies and revealed more effective inhibition of signal transducer and activator of transcription (STAT1) phosphorylation on THP-1 cells treated with serum samples from anti-IFN-γ autoantibodies-positive patients compared with those from HC (2.21 ± 0.33 versus 4.47 ± 1.64, p < 0.05). In flow-cytometry analysis, sera from autoantibodies-positive patients could also significantly more effectively suppress the STAT1 phosphorylation (median,67.28%, interquartile range [IQR] 55.2–78.0%) compared with serum from HC (median,106.7%, IQR 100.0–117.8%, p < 0.05) or autoantibodies-negative patients (median,105.9%, IQR 85.5–116.3%, p < 0.05). Multivariate analysis revealed that the positivity and titers of anti-IFN-γ autoantibodies were significant predictors of severe/critical COVID-19. Compared with non-severe COVID-19 patients, we reveal that a significantly higher proportion of severe/critical COVID-19 patients are positive for anti-IFN-γ autoantibodies with neutralizing capacity.ConclusionOur results would add COVID-19 to the list of diseases with the presence of neutralizing anti-IFN-γ autoAbs. Anti-IFN-γ autoantibodies positivity is a potential predictor of severe/critical COVID-19.

【 授权许可】

CC BY   
© The Author(s) 2023

【 预 览 】
附件列表
Files Size Format View
RO202305152432335ZK.pdf 2609KB PDF download
Fig. 2 1339KB Image download
Fig. 2 881KB Image download
Fig. 1 207KB Image download
Fig. 1 116KB Image download
Fig. 1 409KB Image download
【 图 表 】

Fig. 1

Fig. 1

Fig. 1

Fig. 2

Fig. 2

【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  • [11]
  • [12]
  • [13]
  • [14]
  • [15]
  • [16]
  • [17]
  • [18]
  • [19]
  • [20]
  • [21]
  • [22]
  • [23]
  • [24]
  • [25]
  • [26]
  • [27]
  • [28]
  • [29]
  • [30]
  • [31]
  • [32]
  • [33]
  • [34]
  • [35]
  • [36]
  • [37]
  • [38]
  • [39]
  • [40]
  • [41]
  • [42]
  • [43]
  • [44]
  • [45]
  • [46]
  • [47]
  • [48]
  • [49]
  文献评价指标  
  下载次数:38次 浏览次数:0次